Skip to content

Chinese Medicine

Chinese Medicine is an open access, peer-reviewed journal publishing evidence-based research across all aspects of Chinese medicine, owned by Springer Nature and affiliated with the International Society for Chinese Medicine.

Last updated September 26, 2026

AI crawler reads

No AI crawler has read this profile since Oct 28, 2026.

Overview

Chinese Medicine is an open access, peer-reviewed academic journal dedicated to publishing evidence-based, scientifically justified research and review papers in all aspects of Chinese medicine. Its scope encompasses chemistry, biology, pharmacology, pharmaceutics, engineering, clinical applications, and socioeconomics relevant to Chinese medicine. The journal particularly welcomes interdisciplinary studies that discover new compounds from Chinese medicinal herbs, elucidate molecular and cellular targets and mechanisms of action, develop modern drug delivery and molecular pharmaceutic tools, and evaluate outcomes of hypothesis-driven fundamental, pre-clinical, and clinical research. It is the official journal of the International Society for Chinese Medicine, based in Macau and sponsored by the Macao Foundation and the University of Macau. The editorial office is located in Macao. The journal is well established and indexed by DOAJ, PubMed, Scopus, and SCIE. As of 2025, it has a Journal Impact Factor of 7.4 and a 5-year Journal Impact Factor of 7.2, with a median submission-to-first-decision time of 8 days and 2.3 million downloads in 2025. The Editor-in-Chief is Yitao Wang, MD, and the Deputy Editor is Jian-Bo Wan, PhD. The journal is published by Springer Nature under its BMC (formerly BioMed Central) imprint. It publishes twelve issues per year. Historically, its 2014 Impact Factor was 1.49, ranking 181st out of 254 journals in the Pharmacology and Pharmacy category and 11th out of 24 in Integrative and Complementary Medicine. The journal continues to serve as a key platform for advancing scientific understanding of Chinese medicine through rigorous, open-access publication.

History

Chinese Medicine is a scientific journal published by BioMed Central (now part of Springer Nature). It was established to provide a platform for research on all aspects of Chinese medicine. The journal publishes twelve issues per year. In 2014, its Impact Factor was 1.49, ranking 181st out of 254 journals in the Pharmacology and Pharmacy category and 11th out of 24 in Integrative and Complementary Medicine according to ISI Web of Knowledge. Over time, the journal has grown in impact and visibility. As of 2025, it has a Journal Impact Factor of 7.4 and a 5-year Impact Factor of 7.2, with 2.3 million downloads. It is indexed by DOAJ, PubMed, Scopus, and SCIE. The journal is the official journal of the International Society for Chinese Medicine, based in Macau and sponsored by the Macao Foundation and the University of Macau. The editorial office is based in Macao. The Editor-in-Chief is Yitao Wang, MD, and the Deputy Editor is Jian-Bo Wan, PhD. The journal maintains an open access, peer-reviewed publishing model, making research freely available to all.

  • 2025

    Journal Impact Factor reached 7.4, with 2.3 million downloads and a median submission-to-first-decision time of 8 days.

  • 2014

    Journal Impact Factor was 1.49, ranking 181st out of 254 in Pharmacology and Pharmacy and 11th out of 24 in Integrative and Complementary Medicine.

Products and positioning

Open access, peer-reviewed journal for evidence-based research in Chinese medicine, published by Springer Nature under the BMC imprint.

  • Chinese Medicine journal

    Open access, peer-reviewed journal publishing research on all aspects of Chinese medicine.

Sources6 sources

Cite this profile: Cite the canonical profile. /brand-wiki/chinese-medicine · Editorial policy · How profiles are compiled